Nitric oxide is involved in taurine release in the mouse brain stem under normal and ischemic conditions
- PMID: 17665274
- DOI: 10.1007/s00726-007-0553-9
Nitric oxide is involved in taurine release in the mouse brain stem under normal and ischemic conditions
Abstract
Nitric oxide (NO) has been shown to regulate neurotransmitter release in the brain; both inhibitory and excitatory effects have been seen. Taurine is essential for the development and survival of neural cells and protects them under cell-damaging conditions. In the brain stem, it regulates many vital functions such as cardiovascular control and arterial blood pressure. Now we studied the effects of the NO-generating compounds hydroxylamine (HA), S-nitroso-N-acetylpenicillamine (SNAP) and sodium nitroprusside (SNP) on the release of preloaded [(3)H]taurine under normal and ischemic conditions in slices prepared from the mouse brain stem from developing (7-day-old) to young adult (3-month-old) mice. In general, the effects of NO on the release were somewhat complex and difficult to explain, as expected from the multifunctional role of NO in the central nervous system. The basal initial release under normal conditions was enhanced by the NO donors 5 mM HA and 1.0 mM SNAP at both ages, but SNP was inhibitory in developing mice. The release was markedly enhanced by K(+) stimulation. The effects of HA, SNAP and SNP on the basal release were not antagonized by the NO synthase inhibitor N(G)-nitro-L-arginine (L-NNA, 1.0 mM), demonstrating that mechanisms other than NO synthesis are involved. Taurine release in developing mice in the presence of SNP was reduced by the inhibitor of soluble guanylate cyclase, 1H-(1,2,3)oxadiazolo(4,3-a)quinoxalin-1-one (ODQ), indicating the possible involvement of cGMP. In normoxia, N-methyl-D-aspartate (NMDA, 1.0 mM) enhanced the SNAP- and HA-evoked taurine release in developing mice and the HA-evoked release in adults. In ischemia, both K(+) stimulation and NMDA potentiated the NO-induced release, particularly in the immature mice, probably without the involvement of the NO synthase or cGMP. The substantial release of taurine in the developing brain stem evoked by NO donors together with NMDA might represent signs of important mechanisms against excitotoxicity which protect the brain stem under cell-damaging conditions.
Similar articles
-
Taurine release in mouse brain stem slices under cell-damaging conditions.Amino Acids. 2007;32(3):439-46. doi: 10.1007/s00726-006-0375-1. Epub 2006 Sep 27. Amino Acids. 2007. PMID: 16998716
-
Characteristics of taurine release in slices from adult and developing mouse brain stem.Amino Acids. 2006 Jul;31(1):35-43. doi: 10.1007/s00726-006-0290-5. Epub 2006 May 10. Amino Acids. 2006. PMID: 16680399
-
Modulation of taurine release in ischemia by glutamate receptors in mouse brain stem slices.Amino Acids. 2010 Mar;38(3):739-46. doi: 10.1007/s00726-009-0278-z. Epub 2009 Mar 27. Amino Acids. 2010. PMID: 19326043
-
Taurine and neural cell damage.Amino Acids. 2000;19(3-4):509-26. doi: 10.1007/s007260070003. Amino Acids. 2000. PMID: 11140356 Review.
-
Modulation of taurine release by glutamate receptors and nitric oxide.Prog Neurobiol. 2000 Nov;62(4):407-25. doi: 10.1016/s0301-0082(00)00005-8. Prog Neurobiol. 2000. PMID: 10856611 Review.
Cited by
-
Deletion of TRAAK potassium channel affects brain metabolism and protects against ischemia.PLoS One. 2012;7(12):e53266. doi: 10.1371/journal.pone.0053266. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285272 Free PMC article.
-
Mechanisms of inhibitory amino acid release in the brain stem under normal and ischemic conditions.Neurochem Res. 2010 Dec;35(12):1948-56. doi: 10.1007/s11064-010-0265-5. Epub 2010 Sep 26. Neurochem Res. 2010. PMID: 20872246 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources